FindTrial
Sign In

Clinical application of DFPP in patients with hyperlipidemia

Clinical application of DFPP in patients with hyperlipidemia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080169
Enrollment
Unknown
Registered
2024-01-22
Start date
2023-08-01
Completion date
Unknown
Last updated
2024-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperlipemia

Interventions

DFPP (DFPP model was used to clear blood lipids):None
conventional therapy (DFPP model was not used to clear blood lipids):None

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-75 years old 2. Patients diagnosed with severe pancreatitis (SAP) 3. Serum triglyceride > 11.3mmol/L

Exclusion criteria

Exclusion criteria: 1. Patients undergoing PE treatment 2. Patients with interruption of DFPP treatment

Design outcomes

Secondary

MeasureTime frame
hospital stays;hospitalization expense;—

Primary

MeasureTime frame
Serum triglyceride;cholesterin;Cardiovascular event;Treatment-related complications;—

Countries

China

Contacts

Public ContactWang Fang

West China Hospital of Sichuan University

1106776800@qq.com+86 183 8228 4798

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026